Literature DB >> 10176782

A bootstrap approach to medical decision analysis.

S T Mennemeyer1, L P Cyr.   

Abstract

In economic evaluations of health treatments, the sensitivity of a cost-benefit (CB), cost-effectiveness (CE) or cost-utility (CU) analysis to changes in modeling assumptions, variation in data, and sampling error is important. The typical approach to this problem is ad hoc experimentation; namely, a few parameters of particular interest are changed, either separately or in combination, over plausible ranges. The impact of random variation in the data is seldom explored beyond parametric tests of the statistical significance of estimated coefficients. This note suggests a systematic approach to sensitivity analysis. Bootstrap sampling is used to determine to what extent the patients' response to treatment and economic consequences might vary due to many replications of a clinical trial.

Entities:  

Mesh:

Year:  1997        PMID: 10176782     DOI: 10.1016/s0167-6296(97)00002-7

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  2 in total

1.  The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study.

Authors:  Jihyung Hong; Catherine Reed; Diego Novick; Josep Maria Haro; Frank Windmeijer; Martin Knapp
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Dual mobility versus conventional total hip arthroplasty in femoral neck fractures (DISTINCT): protocol for a registry-nested, open-label, cluster-randomised crossover trial.

Authors:  John E Farey; Tamara Hooper; Tania Alland; Justine M Naylor; Thu-Lan Kelly; Michelle Lorimer; Adriane M Lewin; Margaret Rogers; Chi Kin Law; Jacqueline Close; Steven E Graves; Richard S de Steiger; Peter L Lewis; Sam Adie; Ian A Harris
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.